Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)]. (Q44020716)

29 November 2017

Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)]. (English)

1 reference

29 November 2017

Y N Vashisht Gopal

1

1 reference

29 November 2017

Neelima Konuru

series ordinal

2

1 reference

29 November 2017

Anand K Kondapi

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Archives of Biochemistry and Biophysics

29 November 2017

1 reference

29 November 2017

401

1 reference

29 November 2017

1

1 reference

29 November 2017

53-62

1 reference

Platinum Compounds: a New Class of Potent Antitumour Agents

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Dioxygen Activation by Enzymes Containing Binuclear Non-Heme Iron Clusters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Inhibition of angiogenesis by anthracyclines and titanocene dichloride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Reduction of Lung Metastases by Na[trans-RuCl(4)(DMSO)Im] is not Coupled With the Induction of Chemical Xenogenization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Topoisomerase II poisoning and antineoplastic action by DNA-nonbinding diacetyl and dicarboxaldoxime derivatives of ferrocene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Inhibition of human topoisomerase II by the antitumor metallocenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Topoisomerase II is a cellular target for antiproliferative cobalt salicylaldoxime complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Inhibition of Topoisomerase II Catalytic Activity by Two Ruthenium Compounds: A Ligand-Dependent Mode of Action†

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Reduction and subsequent binding of ruthenium ions catalyzed by subcellular components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Effects of hypoxia and transferrin on toxicity and DNA binding of ruthenium antitumor agents in hela cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Purification and functional characterization of type II DNA topoisomerase from rat testis and comparison with topoisomerase II from liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

A study of the interactions of some polypyridylruthenium (II) complexes with DNA using fluorescence spectroscopy, topoisomerisation and thermal denaturation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Structure and function of type II DNA topoisomerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Disassembly of the nucleus in mitotic extracts: membrane vesicularization, lamin disassembly, and chromosome condensation are independent processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Structure and mechanism of DNA topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

DNA topoisomerases: essential enzymes and lethal targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Non-platinum chemotherapeutic metallopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

Inhibition of cancer cell growth by ruthenium(II) arene complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900037-1

10.1016/S0003-9861(02)00037-1

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference